COVID-19 Associated Mucormycosis and Anbarnesa: Concerning about Important Source of Spores
Abstract
No Abstract
1. Sen M, Honavar SG, Bansal R, et al (2021). Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol, 69(7):1670-92.
2. Singh AK, Singh R, Joshi SR, Misra A (2021). Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr, 2021;15(4):102146-. Epub 2021/05/21.
3. Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H (2016). Mucormycosis in Iran: a systematic review. Mycoses, 59(7):402-15.
4. Ahmadian-Attari MM, Amrollahi Z, Safavi Momeni P, Khodaii Z, Bita'ab A, Hajiagha Bozorgi A (2019). Chemical Constituents of Donkey Dung (Anbarnasara): Questioning the Recent Claims Concerning Therapeutic Effects. Int J Enteric Pathog, 2019;7(1):19-22.
5. Joharchi K, Anaraki Firouz SM, Mashhadiabbas F, Mansouri A, Shafiee H, Taheri JB (2020). Wound Healing and the Effect of ANNAS; a New Product of AnbarNesa. Jundishapur J Nat Pharm Prod, 2020;15(2):e66668. Epub 2020-01-01.
6. Shafiee HA, Moravej-Salehi E (2015). Anbarnesa: The Past Tradition, the Future Medicine. Iran Red Crescent Med J, 2015;17(12):e29536-e.
7. Ziaee A, Zia M, Bayat M, Hashemi J (2016). Identification of Mucorales isolates from soil using morphological and molecular methods. Curr Med Mycol, 2016;2(1):13-9.
2. Singh AK, Singh R, Joshi SR, Misra A (2021). Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr, 2021;15(4):102146-. Epub 2021/05/21.
3. Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H (2016). Mucormycosis in Iran: a systematic review. Mycoses, 59(7):402-15.
4. Ahmadian-Attari MM, Amrollahi Z, Safavi Momeni P, Khodaii Z, Bita'ab A, Hajiagha Bozorgi A (2019). Chemical Constituents of Donkey Dung (Anbarnasara): Questioning the Recent Claims Concerning Therapeutic Effects. Int J Enteric Pathog, 2019;7(1):19-22.
5. Joharchi K, Anaraki Firouz SM, Mashhadiabbas F, Mansouri A, Shafiee H, Taheri JB (2020). Wound Healing and the Effect of ANNAS; a New Product of AnbarNesa. Jundishapur J Nat Pharm Prod, 2020;15(2):e66668. Epub 2020-01-01.
6. Shafiee HA, Moravej-Salehi E (2015). Anbarnesa: The Past Tradition, the Future Medicine. Iran Red Crescent Med J, 2015;17(12):e29536-e.
7. Ziaee A, Zia M, Bayat M, Hashemi J (2016). Identification of Mucorales isolates from soil using morphological and molecular methods. Curr Med Mycol, 2016;2(1):13-9.
| Files | ||
| Issue | Vol 51 No 1 (2022) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v51i1.8320 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Pourazizi M, Mohammadi R, Abtahi-Naeini B. COVID-19 Associated Mucormycosis and Anbarnesa: Concerning about Important Source of Spores. Iran J Public Health. 2022;51(1):223-225.
